Tirzepatide and injectable semaglutide were associated with the greatest weight loss after a year of treatment among several GLP-1 receptor agonists, a recent study showed.“Despite being the ...

Key Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.

Tirzepatide and semaglutide confer greater weight loss than other FDA-approved obesity medications with no significantly higher risk for adverse events, according to findings from a network meta ...

New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including ...

Tirzepatide 15 mg emerged as superior to other GLP-1 agonists for weight loss, for example, in a network meta-analysis of randomized controlled trials looking into obesity management.

FAT jabs have taken the world by storm, offering millions of people with excess weight a chance of a new life. The ‘King Kong ...

Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...

Cardiology and GLP-1s: 10 things to know Advertisement. By: Francesca Mathewes. Thursday, June 26th, 2025. Print ... including the use of newly approved drugs, including GLP-1 receptor agonists like ...

Now, brand-name GLP-1 injections of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are available again. And with compounded GLP-1s largely being phased out , many people will ...